Month: November 2016

IsoRay to Present at 9th Annual LD Micro Investor Conference

…present a corporate overview at the 9th Annual LD Micro Main Event Investor Conference taking place on December 6-8, 2016 at the Luxe Sunset Boulevard Hotel, Los Angeles, CA.

IsoRay Announces “Cesium-131 Brachytherapy for Salvage of Recurrent High Grade Glioma” Poster Presentation at 21st Annual Scientific Meeting of Society for Neuro-Oncology

The poster, entitled “Cs-131 Brachytherapy for Salvage of Recurrent High Grade Glioma,” was presented by Emad Youssef, MD, Radiation Oncologist, Barrow Neurological Institute, Phoenix, Arizona.

IsoRay Announces First Quarter Fiscal 2017 Financial Results

Revenue for the first quarter was $1.08 million, a 14% decrease compared to $1.26 million revenue for the first quarter of fiscal 2016.

Scroll to top